HomeUTHR • NASDAQ
add
United Therapeutics Corporation
Previous close
$258.13
Day range
$255.93 - $262.51
Year range
$204.44 - $262.51
Market cap
11.63B USD
Avg Volume
558.66K
P/E ratio
12.42
Dividend yield
-
Primary exchange
NASDAQ
Top news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 677.70M | 33.70% |
Operating expense | 248.50M | 46.00% |
Net income | 306.60M | 27.27% |
Net profit margin | 45.24 | -4.80% |
Earnings per share | 6.17 | 26.95% |
EBITDA | 371.30M | 24.72% |
Effective tax rate | 23.08% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.71B | -5.43% |
Total assets | 6.50B | 2.35% |
Total liabilities | 1.16B | -5.37% |
Total equity | 5.34B | — |
Shares outstanding | 44.36M | — |
Price to book | 2.14 | — |
Return on assets | 13.04% | — |
Return on capital | 14.08% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | 306.60M | 27.27% |
Cash from operations | 376.50M | 0.45% |
Cash from investing | 735.30M | 432.56% |
Cash from financing | -1.07B | -2,297.53% |
Net change in cash | 43.80M | -78.35% |
Free cash flow | 293.68M | -8.83% |
About
United Therapeutics Corporation is an American publicly traded biotechnology company and public benefit corporation listed on the NASDAQ under the symbol UTHR. It develops novel, life-extending technologies for patients in the areas of lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
Founded
1996
Headquarters
Website
Employees
1,168
